FAIR LAWN, N.J., July 07, 2026 (GLOBE NEWSWIRE) —  Columbia Financial, Inc. (NASDAQ: CLBK), a Delaware corporation and the mid-tier holding company for Columbia Bank (the “Holding Company” or “Columbia”), announced today that Columbia Financial, Inc., a Maryland corporation (the “Company”) and the proposed successor to the Holding Company, has commenced a firm commitment underwritten offering to sell shares of common stock not subscribed for in its second-step conversion subscription offering to the general public at $10.00 per share.  Between the orders received in the subscription offering and the increased orders received in the previously announced resolicitation of maximum purchasers in the subscription offering, which concluded on June 30, 2026, the Company received approximately $1.1 billion in the subscription offering,...

SHANGHAI, China, July 07, 2026 (GLOBE NEWSWIRE) — Texxon Holding Limited (Nasdaq: NPT) (“Texxon”, together with its subsidiaries, the “Company” or “we”), a leading provider of supply chain management services in the plastics and chemical industries in East China, today announced that its Henan polystyrene production facility officially commenced operations in June 2026, marking the completion of the facility’s construction and commissioning process and a significant milestone in the Company’s strategic expansion into manufacturing. The commencement of operations represents an important step in Texxon’s long-term development strategy. Since the launch of the project, the Company has carried out facility construction, equipment installation, system commissioning, personnel training and operational readiness preparations...

Initial Deployment Brings Omni One Systems to Sirica’s First Bay Area Treatment Center Collaboration Builds on Rutgers University Research and Advances Sirica’s Plan to Establish 100 Autism Treatment Centers Nationwide AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) — Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of AI-driven, full-body simulation systems, today announced a strategic partnership with Sirica Therapeutics to deploy its Omni One platform for immersive autism therapy applications. As part of the collaboration, Virtuix has sold and shipped the first two Omni One systems to Sirica’s treatment center in the San Francisco Bay Area. The companies intend to use movement-centered virtual reality and AI-assisted therapeutic experiences to enhance engagement and treatment outcomes for children with...

Fort Lauderdale, FL, July 07, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), a leading provider of AI-powered logistics solutions, today provided a summary of the milestones it achieved during the first half of 2026, and an overview of what it will be focused on accomplishing during the remainder of the year. Algorhythm’s flagship platform, SemiCab continued to experience market adoption from new brands including Coca Cola India and Onida Electronics and expanded contracts with existing customers including Apollo Tyres, Unilever India and Proctor & Gamble India. These companies are using SemiCab’s AI-enabled global freight optimization platform to efficiently and effectively complete shipments across key domestic transportation lanes in India. While SemiCab continued to thrive in India, the...

Transformative transaction intended to maximize stockholder value Repositions the Company to pursue a new strategic direction in the national security sector Strengthens the Company’s ability to deploy capital toward growth initiativesNEW YORK, July 07, 2026 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a provider of wellness and biosecurity solutions, and Face Haus, LLC (“Face Haus”), a leading skincare service and product business, today announced that the Company has entered into a definitive agreement with an affiliate of Face Haus, Express Wellness Group, LLC, under which XWELL will divest its XpresSpa Holdings, LLC and XpresTest, Inc. businesses for $13 million, subject to certain closing adjustments. The divestiture is intended to maximize value for XWELL’s stockholders and help facilitate...

eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease Immunoassay for eMTBR-Tau is available in the NULISAseq™ Neuro 220 panel and as a single-plex assay through the Technology Access Program Data to be featured in Alamar’s workshop at AAIC 2026 FREMONT, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the first commercial eMTBR-Tau immunoassay, now available in the NULISAseq™ Neuro 220 multiplexed panel kits, immediately deployable on the entire installed base of ARGO™ HT instruments, and as a single-plex assay through the company’s Technology...

The demonstrated system achieved short-term fractional frequency stability highlighting the platform’s potential for future chip-scale quantum atomic clock technology. TEL AVIV, Israel, July 07, 2026 (GLOBE NEWSWIRE) — Quantum X Labs Inc. Ltd. (Nasdaq: QXL) (“Quantum X” or the “Company”) today announced the successful demonstration by its wholly-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), a developer of advanced quantum technologies, of a high-sensitivity atomic clock based on Quantum X Labs’s Ramsey Coherent Population Trapping (“Ramsey-CPT”) platform. The demonstrated system achieved short-term fractional frequency stability of 1 × 10⁻13 at 1sec, highlighting the platform’s potential for compact, high-performance timing systems and future chip-scale atomic clock technologies. Atomic clocks are increasingly viewed...

Not for distribution to United States news wire services or for dissemination in the United States.WELLSTAR is expected to become a publicly listed company through a TSXV listing, supported by a Concurrent Financing with gross proceeds of approximately $50 million anchored by strong institutional subscription from a large Canadian bank-owned asset manager and continued support from existing shareholders. The proposed public listing is expected to crystallize the value of WELLSTAR’s underlying assets through an independent public market valuation, while providing a dedicated acquisition currency to support its long-term growth strategy. WELLSTAR is a high growth, profitable pure-play healthcare technology company with a historical three-year organic revenue CAGR of over 20% and expected 2026 Adjusted EBITDA margin of 21%. The Company...

CEO Thomas Equels discusses recent clinical progress, upcoming milestones and the Company’s commitment to advancing Ampligen® for patients with pancreatic cancer Access it here OCALA, Fla., July 07, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the release of its latest CEO Corner segment, featuring Chief Executive Officer Thomas Equels discussing the Company’s continued momentum in pancreatic cancer and the significant clinical, strategic and operational milestones positioning Ampligen® for its next stage of development. In the segment, Mr. Equels highlights the urgent unmet need facing patients with pancreatic cancer, reviews recent progress across the Company’s DURIPANC Phase 2 clinical program evaluating Ampligen® (rintatolimod) in combination with...